Table 2.

In vitro proliferation of γδ T cells in response to pamidronate/IL-2

Healthy donors (%) All patients (%) MM (%) NHL (%) B-CLL (%)
Positive 14/16 (88) 20/41 (49) 12/26 (46) 8/10 (80) 1/5 (20)
Negative 2/16 (12) 21/41 (51) 14/26 (54) 2/10 (20) 4/5 (80)